SEC Tracker
Get the app

Organon OGN

Organon: quarterly report for the quarter ended Sep 30, 2021

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q
Exhibit 10.20
Material contract
Exhibit 10.21
Material contract
Exhibit 10.22
Material contract
Exhibit 10.23
Material contract

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Organon files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cytokinetics CYTK public float $2.5B, Jun 30, 2025
  2. TG Therapeutics TGTX public float $2.5B, Jun 30, 2025
  3. Catalyst Pharmaceuticals CPRX public float $2.5B, Jun 30, 2025
  4. Summit Therapeutics SMMT public float $2.5B, Jun 30, 2025
  5. Xenon Pharmaceuticals XENE public float $2.4B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.